IRadimed Q4: A Bottom-Line Beat, A Special Cash Dividend, Maintain Buy [Seeking Alpha]
iRadimed Corporation (IRMD)
Last iradimed corporation earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
iradimed.com/en-us/investors/investor-contact
Company Research
Source: Seeking Alpha
PhonlamaiPhotoSingular ResearchInvestment ThesisIRMD reported strong Q4:22 results, essentially driven by strength in its monitors segment, which we believe is continuing to maintain strong momentum. The Company is on the cusp of regulatory approval of its next-generation IV pump, the MRidium3870. The U.S. FDA approval of MRidium 3870 is lagging more than anticipated and the Company is resubmitting the application; this productâ??s approval and commercial launch would help IRadimed (NASDAQ:) experience a new product cycle, thereby providing a new top-and bottom-line growth avenue. The total addressable market IRadimed operates in is quite substantial ($3.1 billion), and we expect IRMDâ??s MRI compatible devices to continue to gain market share given their superior safety and efficacy. Wemaintain aBuy rating for the Company given its high revenue growth, improving margins, and solid product pipeline.Quarterly Summaryrevenues rose 25.2% YOY to $ $14.9 million in Q4:22 from $11.9 million
Show less
Read more
Impact Snapshot
Event Time:
IRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRMD alerts
High impacting iRadimed Corporation news events
Weekly update
A roundup of the hottest topics
IRMD
News
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $65.00 price target on the stock.MarketBeat
- Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Singular Research.MarketBeat
- IRADIMED CORPORATION's (NASDAQ:IRMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION To Participate at the 36th Annual Roth ConferenceGlobeNewswire
IRMD
Earnings
- 2/8/24 - Beat
IRMD
Analyst Actions
- 4/5/24 - Singular Research
IRMD
Sec Filings
- 4/3/24 - Form S-3
- 3/1/24 - Form 10-K
- 2/13/24 - Form SC
- IRMD's page on the SEC website